What came back to Earth was shocking: viruses that had evolved in space and were better at killing some annoying bacteria than viruses that had been raised on Earth.
The test that made the ISS into a small war zone
The study, which was published in the journal PLOS Biology, looked at Escherichia coli (E. coli) and a virus that is known to infect it, called phage T7. Phages are viruses that only attack bacteria and not cells in people or animals.
Scientists made the same sets of E. coli that were infected with T7. One group went on a mission to the International Space Station (ISS), and a matching control group stayed in a lab on Earth.
As bacteria and phages fought each other over and over again, both sets were able to change. In microgravity on the ISS, this fight took place. On Earth, the same species fought in normal gravity.
The team changed the rules of how viruses and bacteria interact by changing gravity. This forced evolution to take a different path.
The aim was not just to see whether the viruses still worked in space. Researchers were interested in how the bacteria and phages would react to such an unusual environment and whether those changes could be useful back home.
Microgravity makes the fight slower but sharper for the viruses.
The team quickly saw that infections in space happened more slowly. T7 phages still managed to infect and kill E. coli on the ISS, but they took longer to do it than the phages on Earth.
On Earth, fluids are constantly on the move. Warm liquid rises, cooler liquid sinks, and heavier particles drift downwards. That gentle mixing makes it easier for viruses and bacteria to bump into each other.
In space, there is no up or down in the usual sense. Liquids do not stir themselves. Everything just floats, forming blobs unless it is actively moved.
Genetic mutations: what changed in space
To see what was going on under the hood, scientists sequenced the genomes of both the bacteria and the phages that had spent time on the ISS. They then compared these genomes with those of the ground-based controls.
Both sides of the microscopic war had changed.
- Space-exposed phages carried distinctive mutations that improved their ability to latch onto bacterial receptors and start infections.
- E. coli in space acquired mutations that altered those same receptors and helped the bacteria survive both microgravity and viral attack.
This is classic evolutionary arms-race behaviour: bacteria upgrade their shields, and viruses upgrade their keys. What made the ISS results stand out was the specific pattern of changes, which did not appear in the Earth-grown populations.
Deep mutational scanning: mapping the virus’s “grappling hook”
The team used a tool called deep mutational scanning to study T7’s receptor-binding protein, the structure it uses to attach to a bacterium. This approach lets scientists test thousands of tiny genetic tweaks at once and measure how each affects the virus’s performance.
The space environment effectively ran a giant experiment on the virus’s binding protein, selecting variants that handled slow, sparse encounters especially well.
Those space-favoured changes turned out to be highly relevant on Earth, where some bacterial strains that normally resist T7 became newly vulnerable.
Back to Earth: space-trained viruses hit stubborn infections
When the ISS-evolved phages returned to Earth, researchers tested them against E. coli strains known to cause urinary tract infections (UTIs). These strains are typically resistant to ordinary T7 phages.
The result was unexpected: the space-adapted phages were better at infecting and killing some of these UTI-causing bacteria than the original, Earth-only viruses.
Viruses that had adapted to survive a slow, low-collision life in orbit became more potent against certain disease-linked bacteria on the ground.
That finding was not part of the original plan. The study started as a way to understand basic evolution in microgravity. Instead, it delivered a potential boost for a growing medical field: phage therapy.
Why phage therapy researchers are paying attention
Phage therapy uses viruses that specifically target harmful bacteria. It is drawing new interest as antibiotic resistance spreads and many drugs lose their punch.
Unlike antibiotics, which can kill a broad range of microbes (including friendly ones in your gut), phages are usually highly selective. They latch onto certain receptors on a bacterial cell surface. If those receptors change, the phage may fail.
| Approach | Main target | Key feature |
|---|---|---|
| Antibiotics | Broad range of bacteria | Drug molecules interfere with key cell processes |
| Phage therapy | Specific bacterial strains | Viruses bind to precise receptors and replicate inside bacteria |
That precision is both a strength and a limitation. You get fewer side effects, but also fewer targets. The ISS study suggests microgravity might help fine-tune phages to hit new bacterial strains, including ones that ordinary phages shrug off.
Experts see a possible route to custom phage treatments. By understanding which genetic changes helped space-exposed phages grab bacteria more efficiently, researchers could design or engineer similar traits without always needing to send viruses into orbit.
The price tag and practical hurdles
Sending biological samples to the ISS is not cheap. Launch slots are limited, and experiments must be designed to survive a harsh and tightly controlled environment.
Some scientists argue that the lessons from this study could instead guide work in simulated microgravity on Earth. Devices such as clinostats or random positioning machines can partly mimic weightlessness by constantly rotating samples, reducing the effect of gravity on how fluids settle.
The big question now is whether similar adaptive effects can be reliably reproduced in ground-based microgravity simulators at a far lower cost.
Even if space remains part of the toolkit, any future medical use would require careful safety checks. Phages used in therapy already go through strict testing to ensure they target the intended bacteria and do not carry genes that might, for instance, boost bacterial toxin production.
What this means for astronaut health
The study also matters for people living and working in space. Long missions to the Moon or Mars will expose astronauts to microgravity for months or years, and that environment affects both immune systems and microbes.
Bacteria are known to behave differently in low gravity, sometimes forming thicker biofilms and showing altered virulence. If infections do arise far from Earth, antibiotics might not always behave as expected, and drug supplies will be limited.
Phage therapies tuned for microgravity could become another line of defence, giving flight surgeons more options when treating infections on deep-space missions.
Key terms and ideas worth unpacking
Phage (bacteriophage):
A virus that infects bacteria. It attaches to specific receptors, injects its genetic material, and turns the bacterium into a virus factory until the cell bursts.
Microgravity:
The condition experienced on the ISS and similar platforms, where objects appear weightless. Gravity still exists but everything is in continuous free-fall, so fluids and particles behave very differently from on Earth.
Evolutionary arms race:
A back-and-forth cycle where bacteria evolve defences, such as altered surface receptors, and phages evolve countermeasures, such as modified binding proteins.
What could come next
Future work is likely to map in detail which mutations made the space-evolved phages better at killing resistant E. coli. Those changes could then be recreated using genetic engineering tools in regular labs, avoiding the need to rely on lucky space missions.
Researchers may also run similar ISS experiments with other clinically important bacteria, including those responsible for hospital-acquired infections. Each species has different receptors and defence tricks, so the evolutionary responses in microgravity may vary in telling ways.
In one possible scenario, hospitals in the next decade could draw on a catalogue of phages whose infection machinery was originally shaped in orbit, then refined on Earth. The ISS would have acted as an unusual training ground, nudging viral evolution towards features that standard lab conditions do not produce easily.
For now, the work shows that simply changing gravity changes evolution itself. In doing so, it hints that some of the tools needed to tackle drug-resistant infections might be forged not just in high-tech labs, but in the silent, drifting laboratories circling our planet.
